Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma

Standard

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma : a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). / Tol, Johanna A M G; Gouma, Dirk J; Bassi, Claudio; Dervenis, Christos; Montorsi, Marco; Adham, Mustapha; Andrén-Sandberg, Ake; Asbun, Horacio J; Bockhorn, Maximilian; Büchler, Markus W; Conlon, Kevin C; Fernández-Cruz, Laureano; Fingerhut, Abe; Friess, Helmut; Hartwig, Werner; Izbicki, Jakob R; Lillemoe, Keith D; Milicevic, Miroslav N; Neoptolemos, John P; Shrikhande, Shailesh V; Vollmer, Charles M; Yeo, Charles J; Charnley, Richard M; International Study Group on Pancreatic Surgery (ISGPS).

In: SURGERY, Vol. 156, No. 3, 09.2014, p. 591-600.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Tol, JAMG, Gouma, DJ, Bassi, C, Dervenis, C, Montorsi, M, Adham, M, Andrén-Sandberg, A, Asbun, HJ, Bockhorn, M, Büchler, MW, Conlon, KC, Fernández-Cruz, L, Fingerhut, A, Friess, H, Hartwig, W, Izbicki, JR, Lillemoe, KD, Milicevic, MN, Neoptolemos, JP, Shrikhande, SV, Vollmer, CM, Yeo, CJ, Charnley, RM & International Study Group on Pancreatic Surgery (ISGPS) 2014, 'Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)', SURGERY, vol. 156, no. 3, pp. 591-600. https://doi.org/10.1016/j.surg.2014.06.016

APA

Tol, J. A. M. G., Gouma, D. J., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., Andrén-Sandberg, A., Asbun, H. J., Bockhorn, M., Büchler, M. W., Conlon, K. C., Fernández-Cruz, L., Fingerhut, A., Friess, H., Hartwig, W., Izbicki, J. R., Lillemoe, K. D., Milicevic, M. N., Neoptolemos, J. P., ... International Study Group on Pancreatic Surgery (ISGPS) (2014). Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). SURGERY, 156(3), 591-600. https://doi.org/10.1016/j.surg.2014.06.016

Vancouver

Bibtex

@article{f8c7b17ad8c146bf906bf91a982ec872,
title = "Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)",
abstract = "BACKGROUND: The lymph node (Ln) status of patients with resectable pancreatic ductal adenocarcinoma is an important predictor of survival. The survival benefit of extended lymphadenectomy during pancreatectomy is, however, disputed, and there is no true definition of the optimal extent of the lymphadenectomy. The aim of this study was to formulate a definition for standard lymphadenectomy during pancreatectomy.METHODS: During a consensus meeting of the International Study Group on Pancreatic Surgery, pancreatic surgeons formulated a consensus statement based on available literature and their experience.RESULTS: The nomenclature of the Japanese Pancreas Society was accepted by all participants. Extended lymphadenectomy during pancreatoduodenectomy with resection of Ln's along the left side of the superior mesenteric artery (SMA) and around the celiac trunk, splenic artery, or left gastric artery showed no survival benefit compared with a standard lymphadenectomy. No level I evidence was available on prognostic impact of positive para-aortic Ln's. Consensus was reached on selectively removing suspected Ln's outside the resection area for frozen section. No consensus was reached on continuing or terminating resection in cases where these nodes were positive.CONCLUSION: Extended lymphadenectomy cannot be recommended. Standard lymphadenectomy for pancreatoduodenectomy should strive to resect Ln stations no. 5, 6, 8a, 12b1, 12b2, 12c, 13a, 13b, 14a, 14b, 17a, and 17b. For cancers of the body and tail of the pancreas, removal of stations 10, 11, and 18 is standard. Furthermore, lymphadenectomy is important for adequate nodal staging. Both pancreatic resection in relatively fit patients or nonresectional palliative treatment were accepted as acceptable treatment in cases of positive Ln's outside the resection plane. This consensus statement could serve as a guide for surgeons and researchers in future directives and new clinical studies.",
keywords = "Carcinoma, Pancreatic Ductal, Humans, Lymph Node Excision, Pancreatectomy, Pancreatic Neoplasms, Pancreaticoduodenectomy, Consensus Development Conference, Journal Article, Practice Guideline",
author = "Tol, {Johanna A M G} and Gouma, {Dirk J} and Claudio Bassi and Christos Dervenis and Marco Montorsi and Mustapha Adham and Ake Andr{\'e}n-Sandberg and Asbun, {Horacio J} and Maximilian Bockhorn and B{\"u}chler, {Markus W} and Conlon, {Kevin C} and Laureano Fern{\'a}ndez-Cruz and Abe Fingerhut and Helmut Friess and Werner Hartwig and Izbicki, {Jakob R} and Lillemoe, {Keith D} and Milicevic, {Miroslav N} and Neoptolemos, {John P} and Shrikhande, {Shailesh V} and Vollmer, {Charles M} and Yeo, {Charles J} and Charnley, {Richard M} and {International Study Group on Pancreatic Surgery (ISGPS)}",
note = "Copyright {\textcopyright} 2014 Mosby, Inc. All rights reserved.",
year = "2014",
month = sep,
doi = "10.1016/j.surg.2014.06.016",
language = "English",
volume = "156",
pages = "591--600",
journal = "SURGERY",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma

T2 - a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)

AU - Tol, Johanna A M G

AU - Gouma, Dirk J

AU - Bassi, Claudio

AU - Dervenis, Christos

AU - Montorsi, Marco

AU - Adham, Mustapha

AU - Andrén-Sandberg, Ake

AU - Asbun, Horacio J

AU - Bockhorn, Maximilian

AU - Büchler, Markus W

AU - Conlon, Kevin C

AU - Fernández-Cruz, Laureano

AU - Fingerhut, Abe

AU - Friess, Helmut

AU - Hartwig, Werner

AU - Izbicki, Jakob R

AU - Lillemoe, Keith D

AU - Milicevic, Miroslav N

AU - Neoptolemos, John P

AU - Shrikhande, Shailesh V

AU - Vollmer, Charles M

AU - Yeo, Charles J

AU - Charnley, Richard M

AU - International Study Group on Pancreatic Surgery (ISGPS)

N1 - Copyright © 2014 Mosby, Inc. All rights reserved.

PY - 2014/9

Y1 - 2014/9

N2 - BACKGROUND: The lymph node (Ln) status of patients with resectable pancreatic ductal adenocarcinoma is an important predictor of survival. The survival benefit of extended lymphadenectomy during pancreatectomy is, however, disputed, and there is no true definition of the optimal extent of the lymphadenectomy. The aim of this study was to formulate a definition for standard lymphadenectomy during pancreatectomy.METHODS: During a consensus meeting of the International Study Group on Pancreatic Surgery, pancreatic surgeons formulated a consensus statement based on available literature and their experience.RESULTS: The nomenclature of the Japanese Pancreas Society was accepted by all participants. Extended lymphadenectomy during pancreatoduodenectomy with resection of Ln's along the left side of the superior mesenteric artery (SMA) and around the celiac trunk, splenic artery, or left gastric artery showed no survival benefit compared with a standard lymphadenectomy. No level I evidence was available on prognostic impact of positive para-aortic Ln's. Consensus was reached on selectively removing suspected Ln's outside the resection area for frozen section. No consensus was reached on continuing or terminating resection in cases where these nodes were positive.CONCLUSION: Extended lymphadenectomy cannot be recommended. Standard lymphadenectomy for pancreatoduodenectomy should strive to resect Ln stations no. 5, 6, 8a, 12b1, 12b2, 12c, 13a, 13b, 14a, 14b, 17a, and 17b. For cancers of the body and tail of the pancreas, removal of stations 10, 11, and 18 is standard. Furthermore, lymphadenectomy is important for adequate nodal staging. Both pancreatic resection in relatively fit patients or nonresectional palliative treatment were accepted as acceptable treatment in cases of positive Ln's outside the resection plane. This consensus statement could serve as a guide for surgeons and researchers in future directives and new clinical studies.

AB - BACKGROUND: The lymph node (Ln) status of patients with resectable pancreatic ductal adenocarcinoma is an important predictor of survival. The survival benefit of extended lymphadenectomy during pancreatectomy is, however, disputed, and there is no true definition of the optimal extent of the lymphadenectomy. The aim of this study was to formulate a definition for standard lymphadenectomy during pancreatectomy.METHODS: During a consensus meeting of the International Study Group on Pancreatic Surgery, pancreatic surgeons formulated a consensus statement based on available literature and their experience.RESULTS: The nomenclature of the Japanese Pancreas Society was accepted by all participants. Extended lymphadenectomy during pancreatoduodenectomy with resection of Ln's along the left side of the superior mesenteric artery (SMA) and around the celiac trunk, splenic artery, or left gastric artery showed no survival benefit compared with a standard lymphadenectomy. No level I evidence was available on prognostic impact of positive para-aortic Ln's. Consensus was reached on selectively removing suspected Ln's outside the resection area for frozen section. No consensus was reached on continuing or terminating resection in cases where these nodes were positive.CONCLUSION: Extended lymphadenectomy cannot be recommended. Standard lymphadenectomy for pancreatoduodenectomy should strive to resect Ln stations no. 5, 6, 8a, 12b1, 12b2, 12c, 13a, 13b, 14a, 14b, 17a, and 17b. For cancers of the body and tail of the pancreas, removal of stations 10, 11, and 18 is standard. Furthermore, lymphadenectomy is important for adequate nodal staging. Both pancreatic resection in relatively fit patients or nonresectional palliative treatment were accepted as acceptable treatment in cases of positive Ln's outside the resection plane. This consensus statement could serve as a guide for surgeons and researchers in future directives and new clinical studies.

KW - Carcinoma, Pancreatic Ductal

KW - Humans

KW - Lymph Node Excision

KW - Pancreatectomy

KW - Pancreatic Neoplasms

KW - Pancreaticoduodenectomy

KW - Consensus Development Conference

KW - Journal Article

KW - Practice Guideline

U2 - 10.1016/j.surg.2014.06.016

DO - 10.1016/j.surg.2014.06.016

M3 - SCORING: Journal article

C2 - 25061003

VL - 156

SP - 591

EP - 600

JO - SURGERY

JF - SURGERY

SN - 0039-6060

IS - 3

ER -